Assembly and intracellular trafficking of HLA-B*3501 and HLA-B*3503

被引:15
|
作者
Thammavongsa, Vilasack [2 ]
Schaefer, Malinda [2 ]
Filzen, Tracey [1 ]
Collins, Kathleen L. [1 ]
Carrington, Mary [3 ]
Bangia, Naveen [4 ]
Raghavan, Malini [1 ]
机构
[1] Univ Michigan, Dept Microbiol & Immunol, Sch Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Grad Program Immunol, Sch Med, Ann Arbor, MI 48109 USA
[3] NCI, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick, Frederick, MD 21702 USA
[4] Roswell Pk Canc Inst, Dept Immunol, CCC, Buffalo, NY 14263 USA
关键词
MHC class I; Tapasin; Antigen presentation/processing; TAP transporter; HLA-B*3501; HLA-B*3503; HLA-B*4402; HLA-B*4405; HLA-B*5701; MHC CLASS-I; CYTOTOXIC T-LYMPHOCYTES; COMPLEX CLASS-I; CELL-SURFACE; HLA-B; HISTOCOMPATIBILITY ANTIGEN; MONOCLONAL-ANTIBODIES; ENDOPLASMIC-RETICULUM; PEPTIDE BINDING; HEAVY-CHAINS;
D O I
10.1007/s00251-009-0399-2
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Residue 116 of major histocompatibility complex (MHC) class I heavy chains is an important determinant of assembly, that can influence rates of ER-Golgi trafficking, binding to the transporter associated with antigen processing (TAP), tapasin dependence of assembly, and the efficiency and specificity of peptide binding. Here, we investigated assembly and peptide-binding differences between HLA-B*3501(S116) and HLA-B*3503(F116), two alleles differing only at position 116 of the MHC class I heavy chain, that are associated respectively with normal or rapid AIDS progression. A reduced intracellular maturation rate was observed for HLA-B*3503 in HIV-infected and uninfected cells, which correlated with enhanced binding of HLA-B*3503 to TAP. No significant differences in the intrinsic efficiency of in vitro peptide binding by HLA-B*3501 and HLA-B*3503 were measurable with several common peptides or peptide libraries, and both allotypes were relatively tapasin-independent for their assembly. However, thermostability differences between the two allotypes were measurable in a CD4(+) T cell line. These findings suggest that compared to HLA-B*3501, a reduced intracellular peptide repertoire for HLA-B*3503 could contribute to its slower intracellular trafficking and stronger association with rapid AIDS progression.
引用
收藏
页码:703 / 716
页数:14
相关论文
共 50 条
  • [1] Assembly and intracellular trafficking of HLA-B*3501 and HLA-B*3503
    Vilasack Thammavongsa
    Malinda Schaefer
    Tracey Filzen
    Kathleen L. Collins
    Mary Carrington
    Naveen Bangia
    Malini Raghavan
    [J]. Immunogenetics, 2009, 61 : 703 - 716
  • [2] Motif of HLA-B*3503 peptide ligands
    Steinle, A
    Falk, K
    Rotzschke, O
    Gnau, V
    Stevanovic, S
    Jung, G
    Schendel, DJ
    Rammensee, HG
    [J]. IMMUNOGENETICS, 1996, 43 (1-2) : 105 - 107
  • [3] HLA-B polymorphisms and intracellular assembly modes
    Raghavan, Malini
    Geng, Jie
    [J]. MOLECULAR IMMUNOLOGY, 2015, 68 (02) : 89 - 93
  • [4] A human CTL recognizes a caspase-8-derived peptide on autologous HLA-B*3503 molecules and two unrelated peptides on allogeneic HLA-B*3501 molecules
    Mandruzzato, S
    Stroobant, V
    Demotte, N
    van der Bruggen, P
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (08): : 4130 - 4134
  • [5] A novel HLA-B allele: HLA-B*5419
    Lee, K. W.
    Seo, J. J.
    [J]. TISSUE ANTIGENS, 2009, 74 (05): : 444 - U84
  • [6] A novel HLA-B allele, HLA-B*1803
    Curran, MD
    Williams, F
    Middleton, D
    [J]. TISSUE ANTIGENS, 1996, 48 (06): : 708 - 710
  • [7] HLA-A and HLA-B in Kenya, Africa: Allele frequencies and identification of HLA-B*1567 and HLA-B*4426
    Luo, M
    Embree, J
    Ramdahin, S
    Ndinya-Achola, J
    Njenga, S
    Bwayo, JB
    Pan, S
    Mao, X
    Cheang, M
    Stuart, T
    Brunham, RC
    Plummer, FA
    [J]. TISSUE ANTIGENS, 2002, 59 (05): : 370 - 380
  • [8] Description of three new HLA-B alleles: HLA-B*15:689, HLA-B*35:603 and HLA-B*49:01:25
    Loginova, Maria
    Paramonov, Igor
    [J]. HLA, 2024, 104 (02)
  • [9] Identification of a new HLA-B variant, HLA-B*5615
    Frison, S
    Longhi, E
    de Arias, AE
    Andreini, E
    Scalamogna, M
    Poli, F
    [J]. TISSUE ANTIGENS, 2005, 66 (03): : 238 - 239
  • [10] Description of a new HLA-B allele:: HLA-B*4077
    Sanchez-Gordo, F.
    Balas, A.
    Garcia-Sanchez, F.
    Prat, I.
    Vicario, J. L.
    [J]. TISSUE ANTIGENS, 2007, 70 (04): : 343 - U3